Adial Pharmaceuticals
ADIL
#10837
Rank
A$20.03 M
Marketcap
A$7.63
Share price
36.12%
Change (1 day)
1,542.46%
Change (1 year)

Earnings for Adial Pharmaceuticals (ADIL)

Earnings in 2026 (TTM): -A$83.83 Million

According to Adial Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$12.06 Million, an increase over its 2024 earnings that were of -A$19.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adial Pharmaceuticals from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$83.83 Million595.54%
2025 -A$12.06 Million-39.56%
2024 -A$19.94 Million88.48%
2023 -A$10.58 Million-39.45%
2022 -A$17.47 Million-40.76%
2021 -A$29.49 Million79.17%
2020 -A$16.46 Million26.79%
2019 -A$12.98 Million-26.14%
2018 -A$17.58 Million920.78%
2017 -A$1.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-A$3.27 Million-96.26% Bahamas
NRC Health
NRC
A$22.34 M-125.59%๐Ÿ‡บ๐Ÿ‡ธ USA